Cortés-Funes Castro, Hernán Gómez Martín, Carlos Grávalos Castro, Cristina
Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer [artículo] - Clinical and Translational Oncology, 2011. - 13(3):179-184.
Formato Vancouver:
Grávalos C, Gómez Martín C, Rivera F, Alés I, Queralt B, Márquez A, Jiménez U, Alonso V, et al. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer. Clin Transl Oncol. 2011;13(3):179-84.
PMID: 21421462
Contiene 26 referencias
Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer [artículo] - Clinical and Translational Oncology, 2011. - 13(3):179-184.
Formato Vancouver:
Grávalos C, Gómez Martín C, Rivera F, Alés I, Queralt B, Márquez A, Jiménez U, Alonso V, et al. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer. Clin Transl Oncol. 2011;13(3):179-84.
PMID: 21421462
Contiene 26 referencias
